Article info
Commentary
Are we ready for targeted therapy combinations in HCC?
- Correspondence to Dr Eli Pikarsky, The Lautenberg Center for Immunology and Cancer Research, Hebrew University of Jerusalem Faculty of Medicine, Jerusalem, Israel; peli{at}hadassah.org.il
Citation
Are we ready for targeted therapy combinations in HCC?
Publication history
- Received October 18, 2019
- Revised December 22, 2019
- Accepted December 23, 2019
- First published January 8, 2020.
Online issue publication
March 06, 2020
Article Versions
- Previous version (8 January 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.